6090 — Human Metabolome Technologies Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Annual cashflow statement for Human Metabolome Technologies, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	50.9	262	237	262	270
Depreciation
Non-Cash Items	37.3	-27.8	4.7	-11.2	-14.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-178	25	-37.1	-100	14.5
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Other Operating Cash Flow
Cash from Operating Activities	-34.2	324	285	237	374
Capital Expenditures	-27.9	-146	-117	-34.1	-149
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1.88	-6.2	0.1	1.66	-48.5
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-26	-152	-117	-32.4	-197
Financing Cash Flow Items	—	-0.001	-0.001	-0.001	-0.002
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	86.2	80.5	-13.8	-73.2	-369
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	26	260	152	132	-194